ABO 1009-DP

N/A

Report date: 2026/05/13 09:11:21

Base Information

Drug NameABO 1009-DP
Drug Alias NameABO 1009-DPCOVID-19 mRNA vaccine(Abogen Biosciences Co Ltd)COVID-19-Omicron-mRNA-Vaccine(Abogen Biosciences Co Ltd)SARS-CoV-2 mRNA vaccine(Abogen Biosciences Co Ltd)
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Arab Emirates
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbogen Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAbogen Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A